Advanced Medical Optics, Inc. (AMO), a global leader in ophthalmic surgical devices and eye care products, today reconfirmed its 2006 and 2007 revenue guidance and increased its 2006 and 2007 adjusted earnings-per-share guidance to reflect the impacts of the $450 million convertible senior subordinated note offering (plus up to an additional $50 million of notes subject to the initial purchasers option) purchase of $500 million worth of its common stock and intent to purchase up to $100 million of aggregate principal amount of its outstanding convertible notes.
Finanzen.net
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
FDA Approves Contact Lens for Myopia in Children
The lens focus light on the back of the eye, which is believed to reduce progression of the condition.
HHS Hits Gilead With Patent Infringement Suit Over PrEP Drugs
Truvada was approved in 2012 for use as a PreP regimen, and Descovy was approved in October 2019 as a PrEP regimen.
FDAnews Device Daily Bulletin
ADVANCED MEDICAL OPTICS RECONFIRMS REVENUE GUIDANCE AND UPDATES ADJUSTED EPS
June 9, 2006
